Cargando…
CK1ε drives osteogenic differentiation of bone marrow mesenchymal stem cells via activating Wnt/β-catenin pathway
The treatment of bone defects is a difficult problem in orthopedics. At present, the treatment mainly relies on autologous or allogeneic bone transplantation, which may lead to some complications such as foreign body rejection, local infection, pain, or numbness at the bone donor site. Local injecti...
Autores principales: | Yu, Zhentang, Jiang, Xijia, Yin, Jianjian, Han, Lei, Xiong, Chengwei, Huo, Zhennan, Xu, Jie, Shang, Jingjing, Xi, Kun, Nong, Luming, Huang, Yong, Zhou, Xindie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599756/ https://www.ncbi.nlm.nih.gov/pubmed/37787983 http://dx.doi.org/10.18632/aging.205067 |
Ejemplares similares
-
Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway
por: Shang, JingJing, et al.
Publicado: (2023) -
CK1ε and p120‐catenin control Ror2 function in noncanonical Wnt signaling
por: Curto, Josué, et al.
Publicado: (2018) -
The CK1δ/ϵ-Tip60 Axis Enhances Wnt/β-Catenin Signaling via Regulating β-Catenin Acetylation in Colon Cancer
por: Ning, Jiong, et al.
Publicado: (2022) -
Physiological regulation of β-catenin stability by Tcf3 and CK1ε
por: Lee, Ethan, et al.
Publicado: (2001) -
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
por: Kim, So Young, et al.
Publicado: (2010)